DYN (dyne-tx.com) Enterprise Value-to-Revenue Multiple

dyne-tx.com (DYN) - corporate logo

Negative cash flow and dependence on external capital drive volatility, and this EV/Revenue (annual) multiple chart on GURU.Markets clearly confirms this, where the value 0.00 characterizes this level for Dyne Therapeutics, Inc. (DYN). The business foundation is built upon unique muscle-targeted drug delivery systems and transparent clinical trial management supported by specialized funds.

DYN: Dyne Therapeutics Company Value to Revenue 11/23/2025 - 11/20/2026

dyne-tx.com - analytical breakdowns and key metrics (DYN)

- stock value and consensus price forecast:
- business market valuation indicators:
Fundamental valuation:Dyne Therapeutics DYN
Finished products of Dyne Therapeutics, Inc.

For the biopharmaceutical business of Dyne Therapeutics, Inc. (DYN), where success is driven by biological data rather than macro cycles, the EV/Sales valuation chart serves as an indicator of market expectations. This metric compares the total enterprise value to annual sales volume, excluding the impact of debt load, which allows investors to assess the real value of every dollar of revenue and the risks of overpaying for the growth potential of assets.